Renal Cancer Panel
Test Catalog Information
| Test Catalog Synonyms | |
| EPIC Synonyms | |
| Cerner Primary Mnemonic | Renal Cell Cancer Panel |
| EPIC Display Name | Renal Cancer Panel |
| Allscripts (AEHR) Order Name | Not Orderable |
| Sunrise Clinical Manager (SCM) Order Name | Not Orderable |
| EPIC Inpatient Orderable | Yes |
| EPIC Outpatient Orderable | Yes |
| Cerner Results |
Renal Cell Cancer Panel |
| Clinical Info |
This test is appropriate for patients to verify the genetic basis of cancer in families indicative or suggestive of a predisposition to renal cancer. VHL, MET, FLCN, FH, TSC1 and TSC2 are the genes that are the most often associated with classic forms of hereditary renal cancer, there are several other genes that cause an increased risk of renal cancer. For example, if the family history consists of multiple types of cancer, such as renal cancer in addition to pancreatic cancer, this may be associated with a cancer syndrome such as VHL or Lynch syndrome. Results may help in determining treatment and management, as well as identification of at-risk family members. |
| Specimen Type |
Blood |
| Container |
Lavender Top Tube |
| Collection Instructions |
Container/Tube: Lavender top tube Specimen: 2 - 5 mL Whole Blood Note: Test requires indication for testing and family history submitted with specimen |
| Transport Instructions |
Room Temperature |
| Specimen Stability | |
| Methodology |
Genotyping by Next Generation Sequencing Genes: BAP1, EPCAM, FH, FLCN, MET, MITF, MLH1, MSH2, MSH6, PMS2, PTEN, SDHB, SDHC, SDHD, TP53, TSC1, TSC2, VHL |
| Days Performed |
TAT: 21-29 Days |
| Performing Laboratory |
GeneDx |
| CPT |
81403 81404 81405 81406 81407 |
| PDM |
1659884 |
Desired Epic Build Renal Cancer Panel
| Cerner Primary Mnemonic: | Renal Cell Cancer Panel | ||||||
| PDM | 1659884 | ||||||
| Informatics - Workgroup | Molecular-send outs | ||||||
| Synonyms * | |||||||
| Display Name * | Renal Cancer Panel | ||||||
| Order Entry Specimen Sources * | |||||||
| Order Entry Specimen Types |
Blood
| ||||||
| Specimen Navigator Specimen Types | |||||||
| Specimen Navigator Specimen Sources | |||||||
| Specimen Navigator Short Name | |||||||
| Ordering info (EPIC SmartText) | This test is appropriate for patients to verify the genetic basis of cancer in families indicative or suggestive of a predisposition to renal cancer. VHL, MET, FLCN, FH, TSC1 and TSC2 are the genes that are the most often associated with classic forms of hereditary renal cancer, there are several other genes that cause an increased risk of renal cancer. For example, if the family history consists of multiple types of cancer, such as renal cancer in addition to pancreatic cancer, this may be associated with a cancer syndrome such as VHL or Lynch syndrome. Results may help in determining treatment and management, as well as identification of at-risk family members. | ||||||
| IP Orderable | Yes | ||||||
| OP Orderable | Yes | ||||||
|
AOEs * | |||||||
| AP AOEs | |||||||
| Special History | No | ||||||
| Build Comments | |||||||
| Filter * | genetics | ||||||
| Procedure Category Change | |||||||
Cerner Results
| |||||||
Current Actual EPIC Build as of 10/28/2024
| Procedure Id | 155109 | ||||||||||||
| Pdm | 1659884 | ||||||||||||
| Order Display Name | Renal Cancer Panel | ||||||||||||
| Procedure Name | RENAL CANCER PANEL | ||||||||||||
| Procedure Master Number | LAB155109 | ||||||||||||
| Short Procedure Name | RENAL CANCER PANEL | ||||||||||||
| Category Code | 21.0 | ||||||||||||
| Category Code Record Name | LAB MOLECULAR DIAGNOSTICS ORDERABLES | ||||||||||||
| Synonyms | |||||||||||||
| Clinically Active | Yes | ||||||||||||
| Orderable | Yes | ||||||||||||
| Performable | Yes | ||||||||||||
| Filter Genomics | Generic Genomics Procedure | ||||||||||||
| Reference Link Url | https://labs.northwell.edu/epic/test/155109 | ||||||||||||
| Ordering Instructions | |||||||||||||
| Default Specimen Type | Blood | ||||||||||||
| Specimen Type Pick List | Blood | ||||||||||||
| Specimen Type List | |||||||||||||
| Op Specimen Type List | |||||||||||||
| Specimen Source Pick List | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||
| Specimen Source Default - Male | Blood, Venous | ||||||||||||
| Specimen Source Default - Female | Blood, Venous | ||||||||||||
| Specimen Source List | |||||||||||||
| Op Specimen Source List | |||||||||||||
| Ip Lab Test Components For Report | |||||||||||||
| Op Lab Test Components For Report | |||||||||||||
| Order Questions | ["3048500000"] | ||||||||||||
| Order Questions Record Name | |||||||||||||
| Inpatient Order Questions | ["3048500000"] | ||||||||||||
| Inpatient Order Questions Record Name | |||||||||||||
| Order Specific Question Override | |||||||||||||
| Inpatient Question Override | |||||||||||||
| Location Restrict List Ip | |||||||||||||
| Location Restrict List Ip Record Name | |||||||||||||
| Location Restrict List Include Ip | |||||||||||||
| Location Restrict List Op | |||||||||||||
| Location Restrict List Op Record Name | |||||||||||||
| Location Restrict List Includes Op | |||||||||||||
| Edp Amb Order Specific Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||
| Edp Ip Order Specific Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||
| Edp Ip Specimen Source | |||||||||||||
| Edp Op Specimen Source | |||||||||||||
| Edp Ip Specimen Type | |||||||||||||
| Edp Op Specimen Type | |||||||||||||
| Derived Edp Ip Buttons S | |||||||||||||
| Derived Edp Ip Buttons T | |||||||||||||
| Derived Edp Op Buttons S | |||||||||||||
| Derived Edp Op Buttons T | |||||||||||||
| Ip Orderable | 1 | ||||||||||||
| Op Orderable | 1 | ||||||||||||
EPIC OP AOEs
| |||||||||||||
EPIC IP AOEs
| |||||||||||||
EPIC Components (results)
| |||||||||||||